Last summer, when monkeypox was declared a national1 and global health emergency, a shortage of the Monkeypox vaccine was announced2. In August 2022, the US Food and Drug Administration (USFDA) authorized3 reduced dose (0.1 mL) intradermal (ID) delivery of Monkeypox vaccine to address the supply gaps and extend limited stocks. The EU followed with their own recommendations on intradermal delivery. 4
At PharmaJet, we are proud to display the framed certificate indicating we are the first and only Needle-free Injection Systems (NFIS) to achieve WHO prequalification (E008/050, E008/071), which is a requirement for United Nations agency procurement. But the certificate is also so much more than a fancy frame on the wall: WHO prequalification combined with…
It’s all about teamwork, collaboration, and Quality PharmaJet has expanded its manufacturing capacity to meet the increasing demand as our partners commercialize their vaccines and pharmaceutical products. Read more below about the extraordinary effort and commitment our Quality and Operations teams and our collaborators demonstrated to increase manufacturing capacity amidst the backdrop of the 2021…